Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Orphan Drug Tax Credit

Executive Summary

Orphan Drug Tax Credit: A bill establishing a permanent tax credit for orphan drug development is to be considered by Ways & Means Oversight Subcommittee at a May 9 hearing. The measure, HR 1566, was introduced May 3 by Oversight Chair Johnson (R-Conn.) and co-sponsored by subcommittee ranking minority member Matsui (D-Calif.). Among the witnesses testifying in support of the measure will be Genzyme VP-Government Relations Lisa Raines. Johnson is also holding a hearing on establishing a more general permanent R&D tax credit on May 10...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026160

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel